Commentary: regulatory toxicology and the critical path: predicting long-term outcomes from short-term studies.
Jacobson-Kram
D
D
PhD, DABT, Office of New Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993 (USA). david.jacobsonkram@fda.hhs.gov
D000818:Animals; D006801:Humans; D011237:Predictive Value of Tests; D018675:Toxicity Tests / Q000379:methods*; D014116:Toxicology / Q000379:methods*